It does not really matter who puts in an offer for Neuren ,Acadia who has spent over $200 mill on retts (internally and externally )or another company which would be entitled to the milestones /Royalties.The next milestones will be approval for NNZ2591 trials by the fda and then the NDA approval for trofinetide .
Share Price, page-536
-
- There are more pages in this discussion • 11,159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.72 |
Change
-0.205(1.47%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.94 | $13.96 | $13.50 | $3.667M | 267.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 518 | $13.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.72 | 571 | 23 |
View Market Depth
| Last trade - 14.41pm 06/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |